{"_id":"xwpjB2KPGf5AMICcbD4lvD4AJ9nBeaExNFv4iLpZ49EhS6GiaeGZAk","lastupdate":"2024-09-03T00:00:00.000Z","update_date":"2024-09-03T00:00:00.000Z","lastModified":"Sep 17, 2025","active":1,"confidence_score":81,"confidence_score_reason":"sector, video or image, markets, not claimed","urlname":"somite-ai","minimal_profile":null,"status":"","fullstatus":"","acquired":null,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$c2dke3QGfzIEbIG34OqDVVQd2plzDklbNB3cmxrjmywIbmqlvstPZH.jpeg","name":"Somite.ai","oneliner":" AI-based Platform to Produce Human Tissue for Cell-based Therapies","registrar":null,"website":"https://www.somite.ai","careerspage":"","founded_month":10,"founded_year":2023,"formernames":[],"sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"https://www.linkedin.com/company/98835010","instagram":""},"social":["https://x.com/SomiteAi","https://www.linkedin.com/company/98835010"],"flattenedsociallinks":"https://x.com/SomiteAi|https://www.linkedin.com/company/98835010","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"11-50","employees_exact":48,"patent":null,"raised":57500000,"stage":"A","public_stage":"A","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["Somite","Somite Therapeutics"],"about":"Somite.ai is aiming to become the OpenAI of stem cell biology, developing AI foundation models to produce human tissue for cell therapies at scale for diseases such as diabetes, obesity, and muscular dystrophies. Somite's AI platform, AlphaStem, fuels a virtuous cycle as it enables new cell therapies, generating massive data that further improve the platform, empowering even faster therapy creation with broader applications. The company's pipeline includes the promising SMT-M01 program for Duchenne muscular dystrophy (DMD) and the SMT-B01 program for metabolic disorders.","climatetech_description":null,"is_climatetech_relevant":null,"phone":null,"country":null,"address":{"israeli":[{"id":"z7lDY3dcuGo4xIbQQL1ixbom51jiSCcXpPidDytIHFezIXzOejyuca","city":null,"type":null,"address":"Israel","placeid":"ChIJi8mnMiRJABURuiw1EyBCa2o","notactive":null,"openeddate":null,"registrarid":null,"firstrdcenter":null,"registrarname":null}],"officesabroad":[{"id":"f5MIVCzeosy87gb0yvY4SJo6VZ9CFsVvcpB9NqFbuXtzbFhgjvZ46g","city":"Boston","address":"240 Longwood Ave, Boston, MA 02115, USA","country":"United States","placeid":"ChIJBz4koY5544kRFqD3-RVIW9Q"}]},"headquarter_address":null,"district":null,"news":[{"id":"NTIhsNyFWkxVjGlqWwbBPApmPR3GnZDjXiJD5TBKtOqa46y1xpAtZB","date":"Jun 9, 2025","link":"https://www.themarker.com/magazine/2025-06-09/ty-article-magazine/.premium/00000197-3b0c-da41-a9f7-3f8cbe4c0000","source":"www.themarker.com","visible":1,"analysis":{"tags":"biotechnology","round":null,"company":"Somite.ai","layoffs":null,"summary":"Somite.ai, led by Israeli scientists, is working on a groundbreaking solution to transform stem cells into specific cell types on an industrial scale. This innovation could potentially replace traditional drugs and restore lost functions in the human body. The company is focusing on the precise differentiation of stem cells, which involves exposing them to specific substances at the right time and concentration. If successful, this technology could revolutionize the field of regenerative medicine by providing a scalable method for producing biological cells that can be used therapeutically.","partners":null,"customers":null,"eventType":null,"investors":null,"confidence":9,"key_topics":["stem cells","biotechnology","musculoskeletal","cell differentiation","industrial scale"],"date_of_event":"June 9, 2025","product_stage":"R&D","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":[],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":"developing","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"qRHFok07n3vwuAdUTXSDl6UnkYtJsoNzjbwg3ntA9QZnXckGsklNyI","news_summary":"חברת Somite.ai בהובלת מדענים ישראלים מנסה לפתור בעיה שמעסיקה חוקרים כבר עשורים: איך לגרום לתא גזע להפוך בדיוק למה שצריך — ובקנה מידה תעשייתי. אם תצליח, תאים ביולוגיים יוכלו להחליף תרופות — ולשקם תפקודים שאבדו","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"j0UHR9BBQ87MnUb756SdVorwFIVdeZ26RMeKkvLCX9ooaQlbNqC3ny","date":"May 13, 2025","link":"https://www.calcalistech.com/ctechnews/article/b1zec1ixxl","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"AI-driven platform","round":"Series A","company":"Somite AI","layoffs":null,"summary":"Somite AI, a biotechnology company specializing in AI tools for human cell therapy, has raised over $47 million in a Series A funding round led by Khosla Ventures. The funding will advance the development of DeltaStem, an AI-driven platform aimed at improving human cell production for therapeutic use. The company is targeting applications in Type 1 Diabetes, orthopedic injuries, muscular diseases, and blood disorders. Somite AI has also appointed Fidji Simo as its new CEO of Applications and Board Member. The company aims to revolutionize cell therapy by leveraging AI to enhance the efficiency and scalability of cell production.","partners":null,"customers":null,"eventType":null,"investors":["Khosla Ventures","SciFi Ventures","The Chan Zuckerberg Initiative","Fusion Fund","Ajinomoto","Pitango HealthTech","TechAviv","Harpoon Ventures","Dr. R. Martin Chavez"],"confidence":9,"key_topics":["AI tools","cell therapy","funding","DeltaStem","human cells"],"date_of_event":null,"product_stage":"developing","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$47 million","structured_issues":["Investment","Management Changes"],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":"developing","structuredIssuesShow":"#Investment  #Management Changes","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"9dq552QTfMp1vfZ5SvXoH2iOaC0YFRyLg6uvX63Wys5flQdbPbzM3W","news_summary":"Somite AI secures $47.5 million Series A to expand AI platform for cell therapy | CTech","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"4jeIg00RA7tfmUEMDtMsGls8Ml2WAQI4wqR5yYk1ne7ENZdRLbe6En","date":"May 13, 2025","link":"https://en.globes.co.il/en/article-ai-cell-therapy-development-co-somite-raises-47m-1001510192","source":"en.globes.co.il","visible":1,"analysis":{"tags":"investment","round":"Series A","company":"Somite AI","layoffs":null,"summary":"Somite AI, a cell therapy development company, has secured $47 million in a Series A financing round led by Khosla Ventures, with contributions from several other notable investors. The company is developing DeltaStem, a platform aimed at revolutionizing human cell production by leveraging foundation models and proprietary AI. This funding will accelerate the development of therapeutic programs for various diseases and enhance the DeltaStem platforms capabilities. Somite AI, co-founded by Dr. Micha Breakstone and Dr. Jonathan Rosenfeld, is focused on creating a foundation model for human cells, aiming for significant advancements in developmental biology.","partners":null,"customers":null,"eventType":null,"investors":["Khosla Ventures","SciFi VC","Chan Zuckerberg Initiative","Fusion Fund","Ajinomoto Group Ventures","Pitango HealthTech","TechAviv","Harpoon Ventures","Dr. R. Martin Chavez","Fidji Simo"],"confidence":9,"key_topics":["cell therapy","AI technology","Series A","DeltaStem","human cells"],"date_of_event":"May 13, 2025","product_stage":"R&D","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$47 million","structured_issues":["Investment"],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":"developing","structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"zQOH9sc8XLFh20WO73hea2yPoygdOeloPugV3o8Xo58wnRVEervFlu","news_summary":"Somite AI is building DeltaStem, a platform and foundation model designed to revolutionize the production of human cells.","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"sfY2oCJLvLmX5nKXPObEkhPt6uaZrKPiJMBJG0Qr2l1wlO8fyiCKtn","date":"Sep 10, 2024","link":"https://www.calcalistech.com/ctechnews/article/bymeqqp3a","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"Management Changes","company":"Somite.ai","layoffs":null,"summary":"Somite.ai, an Israeli TechBio company specializing in AI-driven cell replacement therapies, has appointed Shai Kivity as its VP of Strategy & Operations. Kivity brings extensive experience in business development and strategy, having previously served as Chief of Staff at 4M Analytics and in various roles at Alvarez & Marsal. His appointment is expected to accelerate the companys growth and strategic development. Additionally, Somite.ai recently completed a pre-seed funding round of over $10 million, with investments from Astellas Venture Management and Montage Ventures. These developments mark significant steps towards advancing Somite.ais mission in AI-driven drug development.","partners":null,"customers":null,"investors":["Astellas Venture Management","Montage Ventures"],"confidence":10,"key_topics":["Appointment","Strategy","Operations","AI","Funding"],"date_of_event":"October 2023","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"over $10 million","structured_issues":["Management Changes","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Management Changes  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"pBSbIBB6zjKdYkyIfPEXpTZp6Ni4Sb8IGNyFfleq5PTujEi63hX6rw","news_summary":"Before joining Somite.ai, Kivity served as Chief of Staff and first U.S. employee at 4M Analytics. He joins the company after completing over 250 days of reserve duty in the Iron Swords war as a Deputy Battalion Commander in Gaza.","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"m0fXLBjTBJueFXjIZTwjzgAS2WkdintQqzefhaH7c34CuDTEtzVRq3","date":"Sep 3, 2024","link":"https://www.calcalistech.com/ctechnews/article/r1bsomehc","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"funding extension","company":"Somite.ai","layoffs":null,"summary":"Somite.ai, a TechBio company specializing in AI-driven cell replacement therapies, has secured a $4.8 million extension to its initial pre-seed round, bringing its total funding to $10 million. This extension comes just six months after the initial raise. The new funding round includes investments from Astellas Venture Management and Montage Ventures, who will join as Board Observers. The funds will be used to advance the companys AI platform, AlphaStem, and to progress clinical programs SMT-M01 and SMT-B01. The company aims to leverage AI to produce human tissue for cell therapies targeting diseases such as diabetes, obesity, and muscular dystrophies.","partners":["Astellas Venture Management","Montage Ventures"],"customers":null,"investors":["Astellas Venture Management","Montage Ventures","Nachum Shamir","Paul Harris","Dr. Kendra Harris"],"confidence":10,"key_topics":["funding","AI","cell therapy","partnerships","clinical trials"],"date_of_event":"October 2023","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$4.8 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"6zeShmycIGZVRX3i7hcvAjog4w3xCC41ULTQqOfuLxTSg2F8qO7bL9","news_summary":"Somite.ai takes pre-seed to $10M as it eyes to become ‘the OpenAI of stem cell biology’ | CTech","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"Thxt8hufmLlu862nnOIKWKkDks1nI4MCPUWQTAyGMgPjFTV3Q4c1ic","date":"Apr 16, 2024","link":"https://www.calcalistech.com/ctechnews/article/skoaomnga","source":"www.calcalistech.com","visible":1,"analysis":{"tags":"stem cell therapy","company":"Somite","layoffs":null,"summary":"Somite, a company aiming to become a leader in stem cell biology, has raised $5.3 million in pre-seed funding. The investment round was led by Israeli VC TechAviv and included participation from Austin-based VCs Next Coast Ventures, Trust Ventures, Texas Venture Partners, and NY-based Lerer Hippeau. Somite is developing the AlphaStem platform to unlock the principles of cell differentiation and introduce new therapies. The founding team includes CEO Micha Breakstone, who previously sold Chorus.ai for $575 million, and several prominent scientists. The company aims to leverage AI to produce human tissue for cell therapies, potentially curing diseases like Diabetes, Obesity, and Muscular Dystrophies.","partners":["TechAviv","Next Coast Ventures","Trust Ventures","Texas Venture Partners","Lerer Hippeau"],"customers":null,"investors":["TechAviv","Next Coast Ventures","Trust Ventures","Texas Venture Partners","Lerer Hippeau"],"confidence":10,"key_topics":["Funding","Stem cells","AI","Therapies","Innovation"],"date_of_event":"October 2023","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$5.3 million","structured_issues":["Investment","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"FLdtmc3kALEQ3FuztpEf0EhZYmb8kJmpdnHU42IPJacyUrjJUHio2v","news_summary":"Somite raises $5.3 million to incorporate AI in stem cell therapy | CTech","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"Yc0vI9wPyHFBA0K7y2f4uYVbphFJdQfxqvQOnkfjULJucJxpd0zKBX","date":"Apr 9, 2024","link":"https://www.forbes.com/sites/gilpress/2024/04/10/this-startup-wants-to-be-openai-of-stem-cell-therapy-targets-250b-market/?sh=2887a50e77ce","source":"www.forbes.com","visible":1,"analysis":{"tags":"AI, Cell Therapy","company":"Somite.ai","layoffs":null,"summary":"Somite.ai, a startup founded by five scientists, aims to leverage AI to produce human tissue for cell therapies. The company focuses on using embryo digital twins and AI to guide the discovery and optimization of cell replacement therapy (CRT). Somite.ai recently raised $5.3 million in pre-seed funding led by TechAviv, with participation from Next Coast Ventures, Trust Ventures, Texas Venture Partners, and Lerer Hippeau. The startup has already hired two translational scientists and plans to bring its first therapeutic asset to phase-1 clinical trials within the next two years. The market for the therapies they aim to address is estimated at $250 billion.","partners":null,"customers":null,"investors":["TechAviv","Next Coast Ventures","Trust Ventures","Texas Venture Partners","Lerer Hippeau"],"confidence":10,"key_topics":["AI","Cell Therapy","Stem Cells","Funding","Biotech"],"date_of_event":"Last week","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$5.3 million","structured_issues":["Investment","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"52sZ5uTONbOvhJ4HsPPVmNTwTBXHP8RNsdkUkSV3mFF1U16uvuWNPz","news_summary":"Forbes: This Startup Wants To Be OpenAI Of Stem Cell Therapy, Targets $250B Market","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"8EuzPn5c0txzfI5Col9frOvGb5E61TjG8tmdjR8AtdUfOKBmtPpQvV","date":"Feb 29, 2024","link":"https://en.globes.co.il/en/article-stem-cells-meet-ai-1001472419","source":"en.globes.co.il","visible":1,"analysis":{"tags":"stem cell therapy","company":"Somite.ai","layoffs":null,"summary":"Somite.ai, founded by Micha Breakstone and a team of prominent scientists, aims to revolutionize stem cell therapy. The company focuses on manipulating the surroundings of cells to influence their differentiation, with the first goal being muscle stem cells for treating Duchenne Muscular Dystrophy. Clinical trials are expected to begin in two years. The company has raised several million dollars from investors including Lerer Hippeau, Mark VC, and DarkMode. Breakstones previous company, NeuraLight, had $20 million in the bank when he left due to strategic disagreements.","partners":["Harvard Medical School"],"customers":null,"investors":["Lerer Hippeau","Mark VC","DarkMode"],"confidence":10,"key_topics":["stem cells","clinical trials","ALS","muscular dystrophy","investment"],"date_of_event":"February 29, 2024","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"a few millions of dollars","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"aaJ9CwmebT2AOLw5SdMNr6OfrvLxhAbVpAEGVINsmMklhwRLL8RGKz","news_summary":"Together with Harvard and MIT scientists, Micha Breakstone founded Somite.ai, which combines stem cell and AI techniques to develop new therapies.","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":8,"techcommunityinvolvement":null,"mediagallery":[],"tags":["artificial-intelligence","cell-therapy","stem-cells"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2C"],"productstage":"R&D","products":["StemCells","DMD","BAT","AlphaStem"],"geomarkets":["Japan","Europe","Israel","United States"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":16,"lastfunding":"$47.5M","totalrounds":3,"fundingstage":"A","totalfunding":"$57.5M","publicinvestors":16,"lastpublicfunding":47500000,"totalpublicrounds":3,"totalpublicfunding":57500000},"team":[{"name":"Micha Breakstone","email":"micha@somite.ai","phone":"","gender":"Male","userid":"wmdVsj20MaR6LKbyXHSCm0mqsDRzAA84s3npilglITnrdc4yxjwvVe","bounced":false,"claimed":1,"founder":1,"urlname":"micha-breakstone-1","visible":1,"memberid":"yjG1rG1rkrvIghTMfQzhmu0DAf7pHJxKY3S240YwFNmpYdoN16mGpr","position":"Co-founder & CEO","last_name":"Breakstone","claimtoken":"ibi63KAzgdyL8UiiwwgxLqWWTvW6FxZA6h8CTzFZjwWk2EqqJOTVlu","first_name":"Micha","picturekey":null,"claimeddate":"2024-09-04","linkedinurl":"https://www.linkedin.com/in/michabreakstone/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-09-04 11:20:05.000000","initials":"MB","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Olivier Pourquie","email":"olivier@somite.ai","phone":"","gender":"Male","userid":"DmeMBufKmPTQUQ9yTjF9wGHBv2fti6oavxXVT2IUbhjoDxvLld29Gn","bounced":false,"claimed":null,"founder":1,"urlname":"olivier-pourquie","visible":1,"memberid":"N7W5mPVNBtB2Blc0gkgbTo7ROkfMiP1uJiPaGgZcID0is52INTpUwb","position":"Co-founder","last_name":"Pourquie","claimtoken":null,"first_name":"Olivier","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/olivier-pourquie-87182b6/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":null,"initials":"OP","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Jay Shendure","email":"jay@somite.ai","phone":"","gender":"Male","userid":"RXYcnDcrd0unkVc9kYEYeLHJK4DBSCd9e8Ljr0f6f8YYPbpksIytTX","bounced":false,"claimed":null,"founder":1,"urlname":"jay-shendure","visible":1,"memberid":"leuosTDa6IFWHrAf7u0xtgYzAAm3RbIqPVnXxNhCQ9SC3FQQ1cz8XC","position":"Co-founder","last_name":"Shendure","claimtoken":null,"first_name":"Jay","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/jay-shendure-32b2a96/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":null,"initials":"JS","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Allon Klein","email":"allon@somite.ai","phone":"","gender":"Male","userid":"8avDZ2iDIkS1XQZHkjgBPNsPbID5R5IDhGclbxBHEp7yr0YixWvzqp","bounced":false,"claimed":null,"founder":1,"urlname":"allon-klein","visible":1,"memberid":"lyBE8FQHesosQBRwy2fYpnXezKGbeoagfrrtIdgb7hWc5UCBN8BH6T","position":"Co-founder","last_name":"Klein","claimtoken":null,"first_name":"Allon","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/allon-klein-5352b82/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":null,"initials":"AK","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Cliff Tabin","email":"cliff@somite.ai","phone":"","gender":"Male","userid":"YZmHSPakpgddBz8fpSVZErYdEd4fuo0XIhI2SmuwByrPK2yL0kdrbc","bounced":false,"claimed":null,"founder":1,"urlname":"cliff-tabin","visible":1,"memberid":"sVkQ9DRPCFqnkdhEDXND5yvdoi9tz6rCxirzjubFjxJhiXn9w4RNng","position":"Co-founder","last_name":"Tabin","claimtoken":null,"first_name":"Cliff","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/cliff-tabin-129a714/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":null,"initials":"CT","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Jonathan Rosenfeld","email":"jonny@somite.ai","phone":"","gender":"Male","userid":"zV7ES9E1IPH1ZX1Pmm5iuOG8IWZ3gSMJfcn1FirAopSmt27SK1KY1u","bounced":false,"claimed":null,"founder":1,"urlname":"jonathan-rosenfeld","visible":1,"memberid":"22atzW0aJdIKZd9Jcs2uiSxqueV0sWNbuqD0ZzTt0OoSMyACiLn4J3","position":"Co-founder & CTO","last_name":"Rosenfeld","claimtoken":"QVXgjVW9lDqOUS6rh4QY41ooEKLRKBpNxEtoSdeh7uVDnl1CsUPCc7","first_name":"Jonathan","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/jonathan-rosenfeld-56315118/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2025-03-11 16:03:32.000000","initials":"JR","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Shai Kivity","email":"shai@somite.ai","phone":"","gender":"Male","userid":"loaghI8zqycl9kOZpAKD5wmZxISQLv5vGw3orCa8e1uU8htsMLg8Aq","bounced":false,"claimed":1,"founder":0,"urlname":"shai-kivity","visible":1,"memberid":"knLwCGywHo47pADJataYTHyewx8KNv94ABSBN0D9kvMwftzVT99HiG","position":"VP of Strategy & Ops","last_name":"Kivity","claimtoken":"sHJncQEpYFwU0rQO7BgjwyfXHyp3iop1sotB3TprjmybpSJZzeeuQh","first_name":"Shai","picturekey":null,"claimeddate":"2024-09-03","linkedinurl":"https://www.linkedin.com/in/shai-kivity-27b99450/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-09-03 11:07:02.000000","initials":"SK","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":null,"tag_line_edited":null,"sector":null,"sectorverify":null,"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAkNi044UKDA","fullname":"Matan Eblagon"},"biverifydate":"2024-09-03T00:00:00.000Z","crunchbaseid":null,"lastupdator":null,"lastupdator_email":null,"creator":"Matan Eblagon","creator_email":"matane@sncentral.org","createdate":"2024-09-03T00:00:00.000Z","biverification":"Matan Eblagon","sectorverification":null,"affiliatedOrganizations":null,"timeline":[{"id":"E5TPCsxvcO6E8GoVgjQdzWqLq3HoEJw7EVOqfO5U6IMS3xdShTmpgR","date":"May 2025","amount":"$47.5M","source":"https://www.calcalistech.com/ctechnews/article/b1zec1ixxl","eventtype":"FundingRoundEvent","investment":[{"name":"Khosla Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/khosla-ventures","logokey":"$nK6pGW6FzMHOtXrP1YMQsN50Cvt0gIp9P8QxLd2eqWj4QXJ5nGXAkH","tagline":null,"urlname":"/investor_page/khosla-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwOn80JMKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"Q6YffV32dlN7XKi4LSzfkeb0vAvjR21ux7SYPw3e9N0TgAAL0N6ujl","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$nK6pGW6FzMHOtXrP1YMQsN50Cvt0gIp9P8QxLd2eqWj4QXJ5nGXAkH","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead ","followupcaption":""},{"name":"Fusion Fund","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/fusion-fund","logokey":"$0YPEVeobQu9WB7hniFhhn9Lt771jpHADI2k6Gf2Aj4jjAyus91I09y","tagline":"","urlname":"/investor_page/fusion-fund","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCVv_zYCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"5XL1ZD7ocqplOeo6zO53Znc3o1EQlsbszd8RDWvpY6eZt7PLVAhkO0","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$0YPEVeobQu9WB7hniFhhn9Lt771jpHADI2k6Gf2Aj4jjAyus91I09y","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Ajinomoto","type":"Multinational","amount":null,"hidden":true,"country":"Japan","fullurl":"/mnc_page/ajinomoto-1","logokey":"$cwae4xpuYhtSstGbU5LfJBbylOnKUwkX90R5zMUvcZJ1rYCFe7Xi8W.jpeg","tagline":null,"urlname":"/mnc_page/ajinomoto-1","isisraeli":0,"investorid":"4x7Fs14NFAm3CXuQztkPxWuabbC6pGnzScELv932U0k66avHEHtl17","fundingtype":"Multinational","leadpartner":null,"investmentid":"6K3OmOKmGwKO33Pa3k5MVNZa4sEJJrP8XkF3vJ1kzvgkJF0mQ9U6fo","fundingsubtype":null,"investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$cwae4xpuYhtSstGbU5LfJBbylOnKUwkX90R5zMUvcZJ1rYCFe7Xi8W.jpeg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Martin Chavez","type":"Investor","amount":null,"hidden":true,"country":"United States","fullurl":"/investor_page/martin-chavez","logokey":"$jnTaCv8mKdWl25hihw28HKnSShd7aq2HW1HF5XOdOzTovvgFw6EI1R.jpeg","tagline":null,"urlname":"/investor_page/martin-chavez","isisraeli":0,"investorid":"NzYhkd0BNhQ6D1wT8yjIsTU4AJvPRJXOsOCWl7qnWG9rYNJzA0asNj","fundingtype":"Angel","leadpartner":null,"investmentid":"FBkUuvFRGRVj6ml3jVW7GvjQXxS1MjeN6pM7bp9trMMkx64YjGfkLp","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$jnTaCv8mKdWl25hihw28HKnSShd7aq2HW1HF5XOdOzTovvgFw6EI1R.jpeg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"TechAviv","type":"Community","amount":null,"hidden":false,"country":"Israel","fullurl":"/program_page/techaviv","logokey":"$NePNBVuOsCKvitOEzoeJ2GJQphzDLaSwLvuYhGKhEDSQEUf5RyKyo0.jpeg","tagline":"The Israeli Startup Founders Club","urlname":"/program_page/techaviv","isisraeli":null,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4LqW89AKDA","fundingtype":"Founders","leadpartner":null,"investmentid":"JzPeTABkWXCnlOLGAxIQMOKRghtlYa8nR2CI2UeQtI4Xg61CXvTjbl","fundingsubtype":"Founders","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$NePNBVuOsCKvitOEzoeJ2GJQphzDLaSwLvuYhGKhEDSQEUf5RyKyo0.jpeg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Pitango HealthTech","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/pitango-healthtech","logokey":"$F6Cygr894cajpFfKzw59bltMwYAzg7zweRSQNoLbPYayCsjiVjowFM","tagline":null,"urlname":"/investor_page/pitango-healthtech","isisraeli":1,"investorid":"0WDapIjwQhWsxJicr6lGBbSzAQKMumCfRAiMpVUb497i0CiI1Xuiej","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"PUTBE4d0XpN7TF7ZUS7w70IDzT5FjY0SlgBxs20I6QZQDxzZMRpo9b","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$F6Cygr894cajpFfKzw59bltMwYAzg7zweRSQNoLbPYayCsjiVjowFM","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Scifi VC","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/scifi-vc","logokey":"$Ze1mr9tcY9iwlrJMA2CPwlSTgDqHLC7lvtAUZ49fsgCPxFNL6tuZoz","tagline":"","urlname":"/investor_page/scifi-vc","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOD_xursCAw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"ZG9MpBIbJ5XuQKLiAMk5rEwPTjSZD1J2VbAQfC8r2i2g41Q1RoCsOL","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$Ze1mr9tcY9iwlrJMA2CPwlSTgDqHLC7lvtAUZ49fsgCPxFNL6tuZoz","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Chan Zuckerberg Initiative","type":"Investor","amount":null,"hidden":true,"country":"United States","fullurl":"/investor_page/chan-zuckerberg-initiative","logokey":"$CVbyuAjIUgiGp2bTeoOkKCxBoc81gM97Rp0fT9dAYdqDpwk8WP1ejc.png","tagline":null,"urlname":"/investor_page/chan-zuckerberg-initiative","isisraeli":0,"investorid":"MgDGeOZrXcMrGJiKhD6O2ZMbDNut5Pf6F8VW1fI04t2pSRlon85J6t","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"az9nZqDgMWEy8QMj8XsOxc4AUZVEu6GBlhQYlFnCDDSwVNS7Ht69Y0","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$CVbyuAjIUgiGp2bTeoOkKCxBoc81gM97Rp0fT9dAYdqDpwk8WP1ejc.png","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Harpoon Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/harpoon-ventures","logokey":"$L8xOll11NsGctXYMg7QHjX3SMyBdAgizdqoeJloMIi9Dk1yXFRMCNq","tagline":"","urlname":"/investor_page/harpoon-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgJDwxc3fCQw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"tl8HX9c02Wa8LFoaQ0WzfODkQUF6rYFXtyfdMi4Qq86jUPcvfuE52x","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$L8xOll11NsGctXYMg7QHjX3SMyBdAgizdqoeJloMIi9Dk1yXFRMCNq","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":47500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"wcvftPY9BDojRtOksiTUgjD1sRpWvotNi1KVXxNEnUmvyKgDMg8EnQ","date":"Sep 2024","amount":"$4.7M","source":"https://www.calcalistech.com/ctechnews/article/r1bsomehc","eventtype":"FundingRoundEvent","investment":[{"name":"Astellas Venture Management","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/astellas-venture-management","logokey":"$cKOKUp7iyF21CzREKc5793bZu5YjFHk2JMbBNh420YUNzzr05OMJ1p.svg","tagline":null,"urlname":"/investor_page/astellas-venture-management","isisraeli":0,"investorid":"jwhT4pSfBMMuR2g4J4T8w6uFORTtje20iCqRCSWJmGGsF2ULTWKWsw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"RB9YUY9wzjuWQWFZ0ooYGuc4O5F7pfJMu1KT1FfvzqsXLeDswOYjXq","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$cKOKUp7iyF21CzREKc5793bZu5YjFHk2JMbBNh420YUNzzr05OMJ1p.svg","leadcaption":"","followupcaption":""},{"name":"Montage Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/montage-ventures","logokey":"$B5mphIDouhO2m66rEjqZmMHAlZvaIVJUVHtfGYGpPOhke7WhGJBguB.jpeg","tagline":null,"urlname":"/investor_page/montage-ventures","isisraeli":0,"investorid":"vo4yH9ttEFvCMwgyCCtEJnbsV6KWbFEw9NiZFkmHGEHNBFe7Rt0w8Z","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"fah1vuu0g5RXJVuc8kGV0cw4zQV3XAB3u1GtfYsAvOCWXO06pYtSXW","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$B5mphIDouhO2m66rEjqZmMHAlZvaIVJUVHtfGYGpPOhke7WhGJBguB.jpeg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":4700000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"KGdAyjuWcPnTHsulO0ceMejFayokr7XL6p8pMZgXf7zACbgXqcdWCu","date":"Apr 2024","amount":"$5.3M","source":"https://www.forbes.com/sites/gilpress/2024/04/10/this-startup-wants-to-be-openai-of-stem-cell-therapy-targets-250b-market/?sh=222c8fa377ce","eventtype":"FundingRoundEvent","investment":[{"name":"TechAviv Founder Partners","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/techaviv-founder-partners","logokey":"$Mx6QVN5G8Qj70kWIa3WEK9vVM9NyI81zfXemCnDtIIr1b0qcKyWCfk.png","tagline":null,"urlname":"/investor_page/techaviv-founder-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Ivz1LULDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"MJzRq7pVQV94i78JtkmS7ZOzRgeqQ3FcMn1AiDRfTlRSKz6yVnr5jN","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$Mx6QVN5G8Qj70kWIa3WEK9vVM9NyI81zfXemCnDtIIr1b0qcKyWCfk.png","leadcaption":"Lead ","followupcaption":""},{"name":"Next Coast Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/next-coast-ventures","logokey":"$aHWgtq9Zk6tugbAXgkHzq8uI9YG4Acoq2iTb0UixInE1UTXK8Tj2iA","tagline":"","urlname":"/investor_page/next-coast-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgJDCrerjCQw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"428d8rkhX5jHTOKDkY0Rmo7Xr2W3QUcZNINr38M8ERQiTEqLqH7bgS","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$aHWgtq9Zk6tugbAXgkHzq8uI9YG4Acoq2iTb0UixInE1UTXK8Tj2iA","leadcaption":"","followupcaption":""},{"name":"Texas Venture Partners","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/texas-venture-partners","logokey":"$TxRi8tEmpJaXDZriQRA1ZwbU4aeJ7wnHXoECpnzEZacTIpE19xJZve","tagline":null,"urlname":"/investor_page/texas-venture-partners","isisraeli":0,"investorid":"on69fjpLtRhhjNZwRdSUQG6NZJIUjfedhnIXbFTTKPljEOJT09r2Wi","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"8ulzeB7aOlFSWtMNWijLQ32WVQ23L23nxoNfyUpaCAhiExe2YfZNid","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$TxRi8tEmpJaXDZriQRA1ZwbU4aeJ7wnHXoECpnzEZacTIpE19xJZve","leadcaption":"","followupcaption":""},{"name":"Lerer Hippeau Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/lerer-hippeau-ventures","logokey":"$Q60RvUqumlkeSna0gBct8LE7HqFYELmXtO9PAFsRqGALwpuJD609XJ.jpeg","tagline":"","urlname":"/investor_page/lerer-hippeau-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEyJm0CQw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"92uvVP0d3UTLpXcYPNgQrPzYcVzBrQqSWcdUWqeKiXprHWacnZ0I3R","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$Q60RvUqumlkeSna0gBct8LE7HqFYELmXtO9PAFsRqGALwpuJD609XJ.jpeg","leadcaption":"","followupcaption":""},{"name":"Trust Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/trust-ventures","logokey":"$Zl0CXSIBf8G6dVnEk9ET1AouccE2TgqxnJWUZkf2gZzRyj0159G1RS","tagline":"","urlname":"/investor_page/trust-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODPqs-fCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"qjFqs8RVimZq65rfg3bxVaqQOteG9eMDzHtkYn0tmQYMGzmsf6FvkO","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$Zl0CXSIBf8G6dVnEk9ET1AouccE2TgqxnJWUZkf2gZzRyj0159G1RS","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Pre-Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":5300000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"10/2023","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Somite.ai","logourl":"https://storage.googleapis.com/clean-finder-353810/$c2dke3QGfzIEbIG34OqDVVQd2plzDklbNB3cmxrjmywIbmqlvstPZH.jpeg","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$c2dke3QGfzIEbIG34OqDVVQd2plzDklbNB3cmxrjmywIbmqlvstPZH.jpeg","seoabout":"Somite.ai is aiming to become the OpenAI of stem cell biology, developing AI foundation models to produce human tissue for cell therapies at scale for dise...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":7,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Biomaterials & Tissue Engineering","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Biotechnology","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","classificationName":"targetcustomer"}],"classificationDelimited":["IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA>Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","TechnologyClassificationModel>Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Biomaterials & Tissue Engineering#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA"],"classificationsViewModel":"|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA/Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Artificial Intelligence#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Biomaterials & Tissue Engineering#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Biomaterials & Tissue Engineering","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Biomaterials & Tissue Engineering"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Life Sciences","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences","children":[{"title":"Biotechnology","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences>Biotechnology"}]}]}],"coreTechnology":[{"title":"Artificial Intelligence","key":"0-0","path":"TechnologyClassificationModel>Artificial Intelligence"}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Biomaterials & Tissue Engineering","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Artificial Intelligence","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu1rJEIDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Biotechnology","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IeQo-oIDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Biomaterials & Tissue Engineering"],"coreTechnology":["Artificial Intelligence"],"targetCustomer":["Healthcare & Life Sciences","Life Sciences","Biotechnology"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"E5TPCsxvcO6E8GoVgjQdzWqLq3HoEJw7EVOqfO5U6IMS3xdShTmpgR","date":"May 2025","amount":"$47.5M","source":"https://www.calcalistech.com/ctechnews/article/b1zec1ixxl","eventtype":"FundingRoundEvent","investment":[{"name":"Khosla Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/khosla-ventures","logokey":"$nK6pGW6FzMHOtXrP1YMQsN50Cvt0gIp9P8QxLd2eqWj4QXJ5nGXAkH","tagline":null,"urlname":"/investor_page/khosla-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwOn80JMKDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"Q6YffV32dlN7XKi4LSzfkeb0vAvjR21ux7SYPw3e9N0TgAAL0N6ujl","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$nK6pGW6FzMHOtXrP1YMQsN50Cvt0gIp9P8QxLd2eqWj4QXJ5nGXAkH","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"Lead ","followupcaption":""},{"name":"Fusion Fund","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/fusion-fund","logokey":"$0YPEVeobQu9WB7hniFhhn9Lt771jpHADI2k6Gf2Aj4jjAyus91I09y","tagline":"","urlname":"/investor_page/fusion-fund","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCVv_zYCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"5XL1ZD7ocqplOeo6zO53Znc3o1EQlsbszd8RDWvpY6eZt7PLVAhkO0","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$0YPEVeobQu9WB7hniFhhn9Lt771jpHADI2k6Gf2Aj4jjAyus91I09y","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Ajinomoto","type":"Multinational","amount":null,"hidden":true,"country":"Japan","fullurl":"/mnc_page/ajinomoto-1","logokey":"$cwae4xpuYhtSstGbU5LfJBbylOnKUwkX90R5zMUvcZJ1rYCFe7Xi8W.jpeg","tagline":null,"urlname":"/mnc_page/ajinomoto-1","isisraeli":0,"investorid":"4x7Fs14NFAm3CXuQztkPxWuabbC6pGnzScELv932U0k66avHEHtl17","fundingtype":"Multinational","leadpartner":null,"investmentid":"6K3OmOKmGwKO33Pa3k5MVNZa4sEJJrP8XkF3vJ1kzvgkJF0mQ9U6fo","fundingsubtype":null,"investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$cwae4xpuYhtSstGbU5LfJBbylOnKUwkX90R5zMUvcZJ1rYCFe7Xi8W.jpeg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Martin Chavez","type":"Investor","amount":null,"hidden":true,"country":"United States","fullurl":"/investor_page/martin-chavez","logokey":"$jnTaCv8mKdWl25hihw28HKnSShd7aq2HW1HF5XOdOzTovvgFw6EI1R.jpeg","tagline":null,"urlname":"/investor_page/martin-chavez","isisraeli":0,"investorid":"NzYhkd0BNhQ6D1wT8yjIsTU4AJvPRJXOsOCWl7qnWG9rYNJzA0asNj","fundingtype":"Angel","leadpartner":null,"investmentid":"FBkUuvFRGRVj6ml3jVW7GvjQXxS1MjeN6pM7bp9trMMkx64YjGfkLp","fundingsubtype":"Angel","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$jnTaCv8mKdWl25hihw28HKnSShd7aq2HW1HF5XOdOzTovvgFw6EI1R.jpeg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"TechAviv","type":"Community","amount":null,"hidden":false,"country":"Israel","fullurl":"/program_page/techaviv","logokey":"$NePNBVuOsCKvitOEzoeJ2GJQphzDLaSwLvuYhGKhEDSQEUf5RyKyo0.jpeg","tagline":"The Israeli Startup Founders Club","urlname":"/program_page/techaviv","isisraeli":null,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4LqW89AKDA","fundingtype":"Founders","leadpartner":null,"investmentid":"JzPeTABkWXCnlOLGAxIQMOKRghtlYa8nR2CI2UeQtI4Xg61CXvTjbl","fundingsubtype":"Founders","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$NePNBVuOsCKvitOEzoeJ2GJQphzDLaSwLvuYhGKhEDSQEUf5RyKyo0.jpeg","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Pitango HealthTech","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/pitango-healthtech","logokey":"$F6Cygr894cajpFfKzw59bltMwYAzg7zweRSQNoLbPYayCsjiVjowFM","tagline":null,"urlname":"/investor_page/pitango-healthtech","isisraeli":1,"investorid":"0WDapIjwQhWsxJicr6lGBbSzAQKMumCfRAiMpVUb497i0CiI1Xuiej","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"PUTBE4d0XpN7TF7ZUS7w70IDzT5FjY0SlgBxs20I6QZQDxzZMRpo9b","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$F6Cygr894cajpFfKzw59bltMwYAzg7zweRSQNoLbPYayCsjiVjowFM","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Scifi VC","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/scifi-vc","logokey":"$Ze1mr9tcY9iwlrJMA2CPwlSTgDqHLC7lvtAUZ49fsgCPxFNL6tuZoz","tagline":"","urlname":"/investor_page/scifi-vc","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOD_xursCAw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"ZG9MpBIbJ5XuQKLiAMk5rEwPTjSZD1J2VbAQfC8r2i2g41Q1RoCsOL","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$Ze1mr9tcY9iwlrJMA2CPwlSTgDqHLC7lvtAUZ49fsgCPxFNL6tuZoz","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Chan Zuckerberg Initiative","type":"Investor","amount":null,"hidden":true,"country":"United States","fullurl":"/investor_page/chan-zuckerberg-initiative","logokey":"$CVbyuAjIUgiGp2bTeoOkKCxBoc81gM97Rp0fT9dAYdqDpwk8WP1ejc.png","tagline":null,"urlname":"/investor_page/chan-zuckerberg-initiative","isisraeli":0,"investorid":"MgDGeOZrXcMrGJiKhD6O2ZMbDNut5Pf6F8VW1fI04t2pSRlon85J6t","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"az9nZqDgMWEy8QMj8XsOxc4AUZVEu6GBlhQYlFnCDDSwVNS7Ht69Y0","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$CVbyuAjIUgiGp2bTeoOkKCxBoc81gM97Rp0fT9dAYdqDpwk8WP1ejc.png","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""},{"name":"Harpoon Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/harpoon-ventures","logokey":"$L8xOll11NsGctXYMg7QHjX3SMyBdAgizdqoeJloMIi9Dk1yXFRMCNq","tagline":"","urlname":"/investor_page/harpoon-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgJDwxc3fCQw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"tl8HX9c02Wa8LFoaQ0WzfODkQUF6rYFXtyfdMi4Qq86jUPcvfuE52x","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$L8xOll11NsGctXYMg7QHjX3SMyBdAgizdqoeJloMIi9Dk1yXFRMCNq","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":47500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"wcvftPY9BDojRtOksiTUgjD1sRpWvotNi1KVXxNEnUmvyKgDMg8EnQ","date":"Sep 2024","amount":"$4.7M","source":"https://www.calcalistech.com/ctechnews/article/r1bsomehc","eventtype":"FundingRoundEvent","investment":[{"name":"Astellas Venture Management","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/astellas-venture-management","logokey":"$cKOKUp7iyF21CzREKc5793bZu5YjFHk2JMbBNh420YUNzzr05OMJ1p.svg","tagline":null,"urlname":"/investor_page/astellas-venture-management","isisraeli":0,"investorid":"jwhT4pSfBMMuR2g4J4T8w6uFORTtje20iCqRCSWJmGGsF2ULTWKWsw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"RB9YUY9wzjuWQWFZ0ooYGuc4O5F7pfJMu1KT1FfvzqsXLeDswOYjXq","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$cKOKUp7iyF21CzREKc5793bZu5YjFHk2JMbBNh420YUNzzr05OMJ1p.svg","leadcaption":"","followupcaption":""},{"name":"Montage Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/montage-ventures","logokey":"$B5mphIDouhO2m66rEjqZmMHAlZvaIVJUVHtfGYGpPOhke7WhGJBguB.jpeg","tagline":null,"urlname":"/investor_page/montage-ventures","isisraeli":0,"investorid":"vo4yH9ttEFvCMwgyCCtEJnbsV6KWbFEw9NiZFkmHGEHNBFe7Rt0w8Z","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"fah1vuu0g5RXJVuc8kGV0cw4zQV3XAB3u1GtfYsAvOCWXO06pYtSXW","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$B5mphIDouhO2m66rEjqZmMHAlZvaIVJUVHtfGYGpPOhke7WhGJBguB.jpeg","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":4700000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"KGdAyjuWcPnTHsulO0ceMejFayokr7XL6p8pMZgXf7zACbgXqcdWCu","date":"Apr 2024","amount":"$5.3M","source":"https://www.forbes.com/sites/gilpress/2024/04/10/this-startup-wants-to-be-openai-of-stem-cell-therapy-targets-250b-market/?sh=222c8fa377ce","eventtype":"FundingRoundEvent","investment":[{"name":"TechAviv Founder Partners","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/techaviv-founder-partners","logokey":"$Mx6QVN5G8Qj70kWIa3WEK9vVM9NyI81zfXemCnDtIIr1b0qcKyWCfk.png","tagline":null,"urlname":"/investor_page/techaviv-founder-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Ivz1LULDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"MJzRq7pVQV94i78JtkmS7ZOzRgeqQ3FcMn1AiDRfTlRSKz6yVnr5jN","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$Mx6QVN5G8Qj70kWIa3WEK9vVM9NyI81zfXemCnDtIIr1b0qcKyWCfk.png","leadcaption":"Lead ","followupcaption":""},{"name":"Next Coast Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/next-coast-ventures","logokey":"$aHWgtq9Zk6tugbAXgkHzq8uI9YG4Acoq2iTb0UixInE1UTXK8Tj2iA","tagline":"","urlname":"/investor_page/next-coast-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgJDCrerjCQw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"428d8rkhX5jHTOKDkY0Rmo7Xr2W3QUcZNINr38M8ERQiTEqLqH7bgS","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$aHWgtq9Zk6tugbAXgkHzq8uI9YG4Acoq2iTb0UixInE1UTXK8Tj2iA","leadcaption":"","followupcaption":""},{"name":"Texas Venture Partners","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/texas-venture-partners","logokey":"$TxRi8tEmpJaXDZriQRA1ZwbU4aeJ7wnHXoECpnzEZacTIpE19xJZve","tagline":null,"urlname":"/investor_page/texas-venture-partners","isisraeli":0,"investorid":"on69fjpLtRhhjNZwRdSUQG6NZJIUjfedhnIXbFTTKPljEOJT09r2Wi","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"8ulzeB7aOlFSWtMNWijLQ32WVQ23L23nxoNfyUpaCAhiExe2YfZNid","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$TxRi8tEmpJaXDZriQRA1ZwbU4aeJ7wnHXoECpnzEZacTIpE19xJZve","leadcaption":"","followupcaption":""},{"name":"Lerer Hippeau Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/lerer-hippeau-ventures","logokey":"$Q60RvUqumlkeSna0gBct8LE7HqFYELmXtO9PAFsRqGALwpuJD609XJ.jpeg","tagline":"","urlname":"/investor_page/lerer-hippeau-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCEyJm0CQw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"92uvVP0d3UTLpXcYPNgQrPzYcVzBrQqSWcdUWqeKiXprHWacnZ0I3R","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$Q60RvUqumlkeSna0gBct8LE7HqFYELmXtO9PAFsRqGALwpuJD609XJ.jpeg","leadcaption":"","followupcaption":""},{"name":"Trust Ventures","type":"Investor","amount":null,"hidden":false,"country":"United States","fullurl":"/investor_page/trust-ventures","logokey":"$Zl0CXSIBf8G6dVnEk9ET1AouccE2TgqxnJWUZkf2gZzRyj0159G1RS","tagline":"","urlname":"/investor_page/trust-ventures","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODPqs-fCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"qjFqs8RVimZq65rfg3bxVaqQOteG9eMDzHtkYn0tmQYMGzmsf6FvkO","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$Zl0CXSIBf8G6dVnEk9ET1AouccE2TgqxnJWUZkf2gZzRyj0159G1RS","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Pre-Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":5300000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}